Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel

BACKGROUND: The luminal A subtype of breast cancer has a good prognosis and is sensitive to endocrine therapy but is less sensitive to chemotherapy. It is necessary to identify biomarkers to predict chemosensitivity and avoid over-treatment. We hypothesized that miRNAs in the serum might be associat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Li, Qian, Liu, Mei, Ma, Fei, Luo, Yang, Cai, Ruigang, Wang, Liming, Xu, Ningzhi, Xu, Binghe
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2014
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4138038/
https://ncbi.nlm.nih.gov/pubmed/25137071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0104870
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia